Treatment protocol for shingles with post herpetic nuralgia
Reading File
Finding Sources
Finding Sources
Searching PubMed
"postherpetic neuralgia" AND treatment
Reading File
Reading File
Reading File
Reading File
Finding Sources
Searching the Web
shingles herpes zoster postherpetic neuralgia treatment guidelines 2024 2025
Reading File
Reading File
I now have comprehensive data from Harrison's (2025), Andrews' Dermatology, Dermatology 5e, Family Medicine textbook, and recent web sources. I have enough to write a thorough, well-structured answer.
Shingles (Herpes Zoster) + Postherpetic Neuralgia: Treatment Protocol
Background
Herpes zoster (shingles) is caused by reactivation of varicella-zoster virus (VZV) from latency in dorsal root ganglia. Postherpetic neuralgia (PHN) is the most common complication — defined as dermatomal pain persisting ≥90 days after rash onset. PHN occurs in up to 40% of patients >60 years, but <10% of those under 60. Management has two phases: acute phase (antiviral + analgesia) and PHN phase (neuropathic pain management).
Phase 1: Acute Herpes Zoster Treatment
1. Antiviral Therapy
Start within 72 hours of rash onset (benefits can still occur up to 7 days if new lesions are still appearing). Antivirals reduce severity/duration of lesions, acute pain, and lower the risk and severity of PHN.
| Drug | Dose | Duration | Notes |
|---|---|---|---|
| Valacyclovir (preferred) | 1 g PO TID | 7 days | Prodrug of acyclovir; accelerates healing and pain resolution faster than acyclovir; less frequent dosing |
| Famciclovir (preferred) | 500 mg PO TID | 7 days | At least as effective as acyclovir, possibly superior |
| Acyclovir | 800 mg PO 5×/day | 7–10 days | Effective but requires frequent dosing; still widely used |
| IV Acyclovir | 10 mg/kg IV q8h | 7 days | For immunocompromised patients, disseminated disease, or severe complications |
Valacyclovir and famciclovir are preferred over oral acyclovir due to superior pharmacokinetics and simpler dosing. — Harrison's Principles of Internal Medicine 22e
2. Corticosteroids (Adjunct)
- Prednisone (oral): 60 mg/d days 1–7 → 30 mg/d days 8–14 → 15 mg/d days 15–21, when added to antivirals
- Accelerates return to normal activity and reduces acute pain
- Does NOT reduce incidence or severity of PHN — multiple controlled trials confirm this
- Use only in conjunction with antivirals; contraindicated in immunocompromised patients
3. Acute Pain Management
| Severity | Agent |
|---|---|
| Mild–moderate | Acetaminophen, NSAIDs, cool compresses |
| Moderate–severe | Short-course opioids (per established guidelines) |
| Suboptimal control | Gabapentin/pregabalin, TCAs, or nerve blocks as adjuncts |
Phase 2: Postherpetic Neuralgia Treatment
PHN pain is typically burning, shooting, or constant, with allodynia (extreme sensitivity to touch). Treatment is symptom-focused and multimodal.
First-Line Agents
Gabapentinoids
- Gabapentin: Titrate up to 1800–3600 mg/day in divided doses (TID). Demonstrated efficacy for pain AND sleep interference in RCTs. — Dermatology 5e
- Pregabalin: FDA-approved for PHN; more predictable absorption than gabapentin; start 75 mg BID, titrate to 150–300 mg BID
- Starting gabapentin during acute zoster (alongside valacyclovir) in patients with moderate-to-severe pain may prevent PHN — recommended as proactive strategy
Tricyclic Antidepressants (TCAs)
- Amitriptyline, Nortriptyline, Desipramine: Low-dose (25–75 mg/night)
- Number needed to treat (NNT) = 3 (95% CI 2–4) — strong efficacy data
- Act independently of antidepressant mechanism
- Nortriptyline + gabapentin combination reduced pain more than either agent alone in an RCT — Dermatology 5e
- Nortriptyline or desipramine preferred over amitriptyline in elderly (fewer anticholinergic effects)
Second-Line / Topical Agents
| Agent | Details |
|---|---|
| Lidocaine patch 5% | Applied to painful area up to 12 hr/day; minimal systemic absorption; good for allodynia |
| Capsaicin 8% patch | Single 1-hour application by a clinician; reduces PHN pain for up to 12 weeks; mechanism: depletion of substance P |
| EMLA cream | Topical; modest benefit for surface pain |
| Capsaicin cream 0.025–0.075% | OTC; multiple applications daily; burning sensation limits use |
Third-Line / Adjunctive Options
- Opioids (tramadol, oxycodone): Effective but risk/benefit must be weighed; used when first-line agents fail
- Nerve blocks: Sympathetic or epidural blocks; considered in refractory cases
- Biofeedback / physical therapy
- Intrathecal methylprednisolone: Evidence exists but use is limited
Special Situations
| Situation | Management |
|---|---|
| Herpes Zoster Ophthalmicus (V1 branch / tip of nose = Hutchinson sign) | Urgent ophthalmology referral; immediate systemic antivirals; complications reduced from 50% → 20–30% with antivirals |
| Ramsay Hunt Syndrome (facial nerve + ear involvement) | Antiviral + corticosteroid + early referral for facial palsy |
| Immunocompromised patients | IV acyclovir 10 mg/kg q8h; reduce immunosuppression if feasible |
| Disseminated zoster (>20 lesions outside dermatome) | IV acyclovir; evaluate for visceral involvement (lung, liver, CNS) |
Prevention (Reducing PHN Risk)
- Shingrix (recombinant zoster vaccine, RZV): Recommended for all adults ≥50 years, 2 doses; preferred over Zostavax; dramatically reduces HZ and PHN incidence
- Zostavax (live attenuated): Reduced HZ burden of illness by 61%, PHN incidence by 67% in large trials — Textbook of Family Medicine 9e
- Early antiviral initiation (<72 hr) remains the single most effective acute intervention for PHN prevention; a 2024 meta-analysis (PMID 39029866) confirmed that early antiviral treatment and older age are the strongest predictors of PHN incidence
Summary Algorithm
ACUTE ZOSTER (≤72 hr of rash)
├── Start antiviral: Valacyclovir 1g TID ×7d OR Famciclovir 500mg TID ×7d
├── Pain control: Acetaminophen/NSAIDs → Opioids if severe
├── Consider Prednisone (adjunct for acute pain, NOT for PHN prevention)
├── Moderate-severe pain: Add Gabapentin NOW (may prevent PHN)
└── Ophthalmicus/Disseminated/Immunocompromised → IV Acyclovir + Specialist
POSTHERPETIC NEURALGIA (pain >90 days)
├── First-line: Gabapentin 1800–3600mg/day OR Pregabalin 150–300mg/day BID
├── First-line: TCA — Nortriptyline/Amitriptyline 25–75mg at night (NNT=3)
├── Combination: Nortriptyline + Gabapentin > monotherapy
├── Topical: Lidocaine 5% patch (allodynia) / Capsaicin 8% patch (1hr application)
└── Refractory: Opioids, nerve blocks, biofeedback
Sources: Harrison's Principles of Internal Medicine 22e, Andrews' Diseases of the Skin, Dermatology 5e, Textbook of Family Medicine 9e; AAFP 2017 guidelines; PMID 39029866, 37629168, 38050854
This is a shared conversation. Sign in to Orris to start your own chat.